Posted by Michael Wonder on 03 Nov 2017
ICR responds to Government report produced following Accelerated Access Review
3 November 2017 - The Institute of Cancer Research, London, today responds to the Government’s announcement of a new, fast-track route into the NHS for 'breakthrough' medicines and technologies.
This announcement is a response to 2016's Accelerated Access Review.
The new Accelerated Access Pathway will, from April 2018, allow for selected medical technologies and treatments, to begin a process which could make them available up to four years earlier.
The Government aims to reduce the time taken for medicines, deemed to have the greatest potential to change lives, to negotiate the evaluation and financial approvals necessary before the NHS can purchase them.
